CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-04-25 | Cantley Lewis Clayton Jr. Director | Sale | −627 | $55.00 | $34K | 128,429 |
| 2016-04-25 | Cantley Lewis Clayton Jr. Director | Sale | −625 | $55.00 | $34K | 128,443 |
| 2016-03-30 | Cantley Lewis Clayton Jr. Director | Sale | −627 | $38.09 | $24K | 129,056 |
| 2016-03-30 | Cantley Lewis Clayton Jr. Director | Sale | −625 | $38.09 | $24K | 129,068 |
| 2016-03-29 | Cantley Lewis Clayton Jr. Director | Sale | −627 | $36.28 | $23K | 129,683 |
| 2016-03-29 | Cantley Lewis Clayton Jr. Director | Sale | −625 | $36.28 | $23K | 129,693 |
| 2016-02-26 | Cantley Lewis Clayton Jr. Director | Sale | −627 | $38.89 | $24K | 130,459 |
| 2016-02-26 | Cantley Lewis Clayton Jr. Director | Sale | −625 | $38.89 | $24K | 130,465 |
| 2016-02-25 | Cantley Lewis Clayton Jr. Director | Sale | −627 | $36.90 | $23K | 131,086 |
| 2016-02-25 | Cantley Lewis Clayton Jr. Director | Sale | −625 | $36.90 | $23K | 131,090 |
| 2016-02-16 | Hoerter Steven L. Chief Commercial Officer | Grant or award · Stock option (right to buy) | +100,000 | 100,000 | ||
| 2016-02-16 | Biller Scott Chief Scientific Officer | Grant or award · Stock option (right to buy) | +45,220 | 328,691 | ||
| 2016-02-16 | Schenkein David P Chief Executive Officer | Grant or award · Stock option (right to buy) | +102,000 | 997,501 | ||
| 2016-02-16 | Goddard Glenn Senior Vice President, Finance | Grant or award · Stock option (right to buy) | +20,330 | 108,572 | ||
| 2016-02-16 | Bowden Christopher Chief Medical Officer | Grant or award · Stock option (right to buy) | +45,220 | 177,220 | ||
| 2016-02-03 | Biller Scott Chief Scientific Officer | Exercise or conversion | +10,000 | $0.47 | $5K | 59,070 |
| 2016-02-03 | Biller Scott Chief Scientific Officer | Exercise or conversion · Stock option (right to buy) | −10,000 | 283,471 | ||
| 2016-01-29 | Cantley Lewis Clayton Jr. Director | Sale | −627 | $41.52 | $26K | 131,713 |
| 2016-01-29 | Cantley Lewis Clayton Jr. Director | Sale | −625 | $41.52 | $26K | 131,715 |
| 2016-01-28 | Cantley Lewis Clayton Jr. Director | Sale | −627 | $44.33 | $28K | 132,340 |
Page 82 of 93 · 1,853 trades